Predictive oncology stock.

Hernandez-Boussard, T., Macklin, P., Greenspan, E.J. et al. Digital twins for predictive oncology will be a paradigm shift for precision cancer care. Nat Med 27, 2065–2066 (2021 ...

Predictive oncology stock. Things To Know About Predictive oncology stock.

Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ...The first split for POAI took place on October 29, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of POAI owned pre-split, the shareholder ...Predictive Oncology Inc (NASDAQ:POAI) 3.22 Delayed Data As of 4:00pm ET +0.13 / +4.21% Today’s Change 2.47 Today ||| 52-Week Range 13.88 -47.49% Year-to-Date …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Predictive Oncology share forecasts, stock quote and buy / sell signals below. According to present data Predictive Oncology's POAI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).The estimated Net Worth of Robert L Myers is at least $560 Thousand dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $232,324 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.

Predictive Oncology Market Cap: 12.59M, Enterprise value: N/A, P/E: -0.82, PEG ratio: -0.01, EPS: -3.13, Revenue: 1.80M, EBITDA: -10.25M, Income: -33.59M, ...

Nov 13, 2023 · POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35... Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings data on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to …

Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the …Raymond Vennare POAI stock SEC Form 4 insiders trading. Raymond has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Raymond bought 5,000 units of POAI stock worth $2,600 on 2 December 2022.. The largest trade Raymond's ever made was buying 5,000 units …PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that ...

View the latest Predictive Oncology Inc. (POAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Find the latest Ikena Oncology, Inc. (IKNA) stock quote, history, news and other vital information to help you with your stock trading and investing.

In the world of prophecy and spirituality, Perry Stone is a well-known figure who has gained a significant following for his insights into future events. One of Perry Stone’s notable predictions revolves around economic shifts and a possibl...The estimated Net Worth of Robert L Myers is at least $346 Thousand dollars as of 25 September 2023. Mr Myers owns over 1,667 units of Predictive Oncology stock worth over $18,305 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.Here are three top AI stocks trading under $10 a share. Lantern Pharma Inc. ( LTRN ): A small, potential game-changer in the fight against cancer. Predictive Oncology (POAI): While risky, POAI ...Jun 27, 2023 · Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ... We changed our name from Skyline Medical, Inc. to Precision Therapeutics, Inc. on February 1, 2018 and to Predictive Oncology Inc. on June 13, 2019. Our address is 2915 Commers Drive, Suite 900, Eagan, Minnesota 55121. Our telephone number is (651) 389-4800, and our website address is www.predictive-oncology.com.

The estimated Net Worth of Carl I. Schwartz is at least $1.17 Milion dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over $741,217 and over the last 7 years he sold POAI stock worth over $544. In addition, he makes $433,000 as CEO & Director at Predictive Oncology.The Predictive Oncology stock forecast for tomorrow is $ 2.88, which would represent a -0.32% loss compared to the current price. In the next week, the price of POAI is expected to increase by 14.32% and hit $ 3.30. As far as the long-term Predictive Oncology stock forecast is concerned, here ... २०२३ नोभेम्बर १४ ... ... Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of September 30, 2023 and December 31, 2022, 792, 792. Common ...Aug 10, 2023 · Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ... Traffic data maps play a crucial role in predictive analytics, providing valuable insights into the flow of traffic on roads and highways. Traffic data maps are visual representations that showcase real-time or historical traffic conditions...

The next two stocks on this list of AI penny stocks with huge potential combine the benefits of AI with biotechnology. And both have similar missions. The first of these is Predictive Oncology ...

EAGAN, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused …Predictive Oncology Inc (POAI) Message Board - Company Name: Predictive Oncology Inc, Stock Symbol: POAI, Industry: Medical - Healthcare - Total Posts: 4357 - Last Post: 07/15/2023 01:24:11 PM - company/specific stock boardOncology Pharma Stock Forecast. Is Oncology Pharma Stock Undervalued? The current Oncology Pharma [ ONPH] share price is $0.0000. The Score for ONPH is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ONPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country. The shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...The Predictive Oncology Inc ( POAI) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $5.0628, representing a +68.20% increase from the current price of $3.01. The highest analyst price target is $9.9664, and the lowest is $0.1593. Based on our technical indicators, the current sentiment ...

Outcomes can be predicted mathematically using statistics or probability. To determine the probability of an event occurring, take the number of the desired outcome, and divide it by the possible number of outcomes. With statistics, an outc...

Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …

The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. 17 days ago • Morningstar View morePeople use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Artificial intelligence in drug discovery. The global AI in drug discovery market is expected to reach $1.1 billion this year, with oncology at 20% of revenue share, …1 equities research analysts have issued 1-year target prices for Cardiff Oncology's stock. Their CRDF share price targets range from $13.00 to $13.00. On average, they expect the company's share price to reach $13.00 in the next twelve months. This suggests a possible upside of 956.9% from the stock's current price.Predictive Oncology Inc. analyst ratings, historical stock prices, earnings estimates & actuals. POAI updated stock price target summary.Their ZOM share price targets range from $6.00 to $6.00. On average, they expect the company's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 3,421.1% from the stock's current price. View analysts price targets for ZOM or view top-rated stocks among Wall Street analysts.Predictive Oncology Inc. Watch list After Hours Last Updated: Nov 13, 2023 7:52 p.m. EST Delayed quote $ 3.0500 -0.14 -4.39% After Hours Volume: 35 Advanced …Aug 16, 2023 · Predictive Oncolog y : Offers a compelling use case for AI in the area of cancer research. Remark ( MARK ): One of the smallest of small-cap stocks may have one of the biggest upsides of any AI stock. Predictive Oncology Inc (NASDAQ:POAI) 3.22 Delayed Data As of 4:00pm ET +0.13 / +4.21% Today’s Change 2.47 Today ||| 52-Week Range 13.88 -47.49% Year-to-Date …EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ...

The shares of common stock described above (but not the warrants or the shares of common stock underlying the warrants) were offered by the Company in the registered direct offerings pursuant to ...The Predictive Oncology Inc stock price gained 2.03% on the last trading day (Friday, 24th Nov 2023), rising from $2.95 to $3.01. During the last trading day the stock fluctuated 6.77% from a day low at $2.84 to a day high of $3.03. The price has fallen in 7 of the last 10 days and is down by -10.68% for this period.Forecst.com predicts future values using technical analysis of a large number of analytical parameters. POAI stock returns are also predicted based on historical data. According to our research, POAI stock is a bad long-term investment. POAI share price has been in a bear cycle for the past year. Predictive Oncology Inc. stock trend is …Instagram:https://instagram. free stocks from webullstock omfhydro weed growdental insurance me FY 2021 Financial results. The Company recorded revenue of $1,420,680 in 2021, compared to $1,252,272 in 2020. Skyline division was responsible for the majority of the revenue, but Soluble showed ...The shares of Series F Preferred Stock will be distributed to such recipients a. EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology ... chevron stock forecast 2025corning stocks Forecst.com predicts future values using technical analysis of a large number of analytical parameters. POAI stock returns are also predicted based on historical data. According to our research, POAI stock is a bad long-term investment. POAI share price has been in a bear cycle for the past year. Predictive Oncology Inc. stock trend is … best medicaid plan nyc Nov 30, 2023 · Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ... Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Predictive Oncology's business for …